We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEN
2651
DELISTED
Denbury Inc.
DEN
$58K ﹤0.01%
756
-3,009
-80% -$238K
AIMC
2652
DELISTED
Altra Industrial Motion Corp
AIMC
$58K ﹤0.01%
1,112
-1,215
-52% -$66.7K
ZGNX
2653
DELISTED
Zogenix, Inc.
ZGNX
$58K ﹤0.01%
3,545
+1,174
+50% +$17.2K
MNR
2654
DELISTED
Monmouth Real Estate Investment Corp
MNR
$58K ﹤0.01%
2,755
-1,609
-37% -$32.5K
ALRM icon
2655
Alarm.com
ALRM
$2.73B
$57K ﹤0.01%
668
-1,939
-74% -$159K
AMPY icon
2656
Amplify Energy
AMPY
$198M
$57K ﹤0.01%
+18,184
New +$61K
AQN icon
2657
Algonquin Power & Utilities
AQN
$4.53B
$57K ﹤0.01%
4,000
-3,514
-47% -$50.3K
AXGN icon
2658
Axogen
AXGN
$2.62B
$57K ﹤0.01%
6,099
-816
-12% -$9.79K
BANF icon
2659
BancFirst
BANF
$3.89B
$57K ﹤0.01%
807
-1,165
-59% -$76.9K
DHX icon
2660
DHI Group
DHX
$171M
$57K ﹤0.01%
+9,200
New +$48.7K
ECPG icon
2661
Encore Capital Group
ECPG
$2.2B
$57K ﹤0.01%
906
-586
-39% -$33K
IRMD icon
2662
iRadimed
IRMD
$1.11B
$57K ﹤0.01%
1,238
-1,807
-59% -$72.9K
KGC icon
2663
Kinross Gold
KGC
$32.4B
$57K ﹤0.01%
9,918
+3,444
+53% +$20.6K
LEVI icon
2664
Levi Strauss
LEVI
$8.68B
$57K ﹤0.01%
2,263
-1,295
-36% -$33.4K
MVV icon
2665
ProShares Ultra MidCap400
MVV
$166M
$57K ﹤0.01%
813
-22,134
-96% -$1.51M
SRDX
2666
DELISTED
Surmodics
SRDX
$57K ﹤0.01%
1,181
+416
+54% +$21K
WW
2667
DELISTED
WW International
WW
$57K ﹤0.01%
3,524
-9,341
-73% -$168K
ROIC
2668
DELISTED
Retail Opportunity Investments Corp.
ROIC
$57K ﹤0.01%
2,949
-8,876
-75% -$163K
GRTS
2669
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$57K ﹤0.01%
4,428
-11,096
-71% -$123K
AKUS
2670
DELISTED
Akouos Inc
AKUS
$57K ﹤0.01%
6,703
+5,928
+765% +$53.2K
EPAY
2671
DELISTED
Bottomline Technologies Inc
EPAY
$57K ﹤0.01%
998
-3,182
-76% -$149K
FLOW
2672
DELISTED
SPX FLOW, Inc.
FLOW
$57K ﹤0.01%
662
-8,904
-93% -$716K
CDLX icon
2673
Cardlytics
CDLX
$24.9M
$56K ﹤0.01%
84
-1
-1% -$764
COLL icon
2674
Collegium Pharmaceutical
COLL
$916M
$56K ﹤0.01%
3,014
+1,206
+67% +$23.5K
CRGY icon
2675
Crescent Energy
CRGY
$4.03B
$56K ﹤0.01%
+4,434
New +$61.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.